India faces challenges because of low investment in public health programs, high endemicity in difficult-to-reach locations, and persisting diagnostic gaps.
Published in Indian Journal of Medical Research, study classifies nearly 10% prescriptions as 'unacceptable', says such lapses can lead to adverse drug reactions & risk patient health.
Swiss drugmaker Roche Pharma says Ocrelizumab can help manage multiple sclerosis & impede disability progression. Doctors welcome launch but caution against potential side effects.
The two drugs – Leqembi and Donanemab – are the first to offer real hope of slowing the fatal disease for 6.5 million Americans living with the disease.
At least 70 children died from acute kidney injury in Gambia last year, cases the WHO linked to medicines made by Indian drugmaker Maiden Pharmaceuticals.
Revumenib found to be promising in 2 studies by US researchers published in 'Nature' Wednesday. Leukaemia accounted for nearly 4% of global cancer deaths in 2020.
According to a report by Macquarie, India’s data centre market is estimated to double by 2027. India currently has 1.4 gigawatts of operational data centre capacity.
At 11th edition of Indo-Pacific Regional Dialogue in New Delhi, Navy Chief Admiral Dinesh K Tripathi said there are three major currents shaping this maritime 'dynaxity'.
On 21 Oct, a buzz went up that the govt had released full list of gallantry award recipients along with Op Sindoor citations. I put an AI caddy on the job. It took me into a never-ending rabbit hole.
COMMENTS